Robert Sean Hill
Howard Hughes Medical Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert Sean Hill.
Science | 2008
Eric M. Morrow; Seung Yun Yoo; Steven W. Flavell; Tae Kyung Kim; Yingxi Lin; Robert Sean Hill; Nahit Motavalli Mukaddes; Soher Balkhy; Generoso G. Gascon; Asif Hashmi; Samira Al-Saad; Janice Ware; Robert M. Joseph; Rachel Greenblatt; Danielle Gleason; Julia A. Ertelt; Kira Apse; Adria Bodell; Jennifer N. Partlow; Brenda J. Barry; Hui Yao; Kyriacos Markianos; Russell J. Ferland; Michael E. Greenberg; Christopher A. Walsh
To find inherited causes of autism-spectrum disorders, we studied families in which parents share ancestors, enhancing the role of inherited factors. We mapped several loci, some containing large, inherited, homozygous deletions that are likely mutations. The largest deletions implicated genes, including PCDH10 (protocadherin 10) and DIA1 (deleted in autism1, or c3orf58), whose level of expression changes in response to neuronal activity, a marker of genes involved in synaptic changes that underlie learning. A subset of genes, including NHE9 (Na+/H+ exchanger 9), showed additional potential mutations in patients with unrelated parents. Our findings highlight the utility of “homozygosity mapping” in heterogeneous disorders like autism but also suggest that defective regulation of gene expression after neural activity may be a mechanism common to seemingly diverse autism mutations.
Neurology | 2005
Volney L. Sheen; An Jansen; Ming-Hui Chen; Elena Parrini; Timothy R. Morgan; R. Ravenscroft; Vijay S. Ganesh; T. Underwood; James S. Wiley; Richard J. Leventer; R. R. Vaid; D. E. Ruiz; G. M. Hutchins; J. Menasha; Judith P. Willner; Y. Geng; Karen W. Gripp; L. Nicholson; Elizabeth Berry-Kravis; Adria Bodell; Kira Apse; Robert Sean Hill; François Dubeau; F. Andermann; James Barkovich; Eva Andermann; Yin Yao Shugart; Pierre Thomas; Maurizio Viri; Pierangelo Veggiotti
Objective: To define the clinical, radiologic, and genetic features of periventricular heterotopia (PH) with Ehlers-Danlos syndrome (EDS). Methods: Exonic sequencing and single stranded conformational polymorphism (SSCP) analysis was performed on affected individuals. Linkage analysis using microsatellite markers on the X-chromosome was performed on a single pedigree. Western blotting evaluated for loss of filamin A (FLNA) protein and Southern blotting assessed for any potential chromosome rearrangement in this region. Results: The authors report two familial cases and nine additional sporadic cases of the EDS-variant form of PH, which is characterized by nodular brain heterotopia, joint hypermobility, and development of aortic dilatation in early adulthood. MRI typically demonstrated bilateral nodular PH, indistinguishable from PH due to FLNA mutations. Exonic sequencing or SSCP analyses of FLNA revealed a 2762 delG single base pair deletion in one affected female. Another affected female harbored a C116 single point mutation, resulting in an A39G change. A third affected female had a 4147 delG single base pair deletion. One pedigree with no detectable exonic mutation demonstrated positive linkage to the FLNA locus Xq28, an affected individual in this family also had no detectable FLNA protein, but no chromosomal rearrangement was detected. Conclusion: These results suggest that the Ehlers-Danlos variant of periventricular heterotopia (PH), in part, represents an overlapping syndrome with X-linked dominant PH due to filamin A mutations.
The New England Journal of Medicine | 2014
Saumya Shekhar Jamuar; Anh Thu N Lam; Martin Kircher; Alissa M. D'Gama; Jian Wang; Brenda J. Barry; Xiaochang Zhang; Robert Sean Hill; Jennifer N. Partlow; Aldo Rozzo; Sarah Servattalab; Bhaven K. Mehta; Meral Topçu; Dina Amrom; Eva Andermann; Bernard Dan; Elena Parrini; Renzo Guerrini; Ingrid E. Scheffer; Samuel F. Berkovic; Richard J. Leventer; Yiping Shen; Bai-Lin Wu; A. James Barkovich; Mustafa Sahin; Bernard S. Chang; Michael J. Bamshad; Deborah A. Nickerson; Jay Shendure; Annapurna Poduri
BACKGROUND Although there is increasing recognition of the role of somatic mutations in genetic disorders, the prevalence of somatic mutations in neurodevelopmental disease and the optimal techniques to detect somatic mosaicism have not been systematically evaluated. METHODS Using a customized panel of known and candidate genes associated with brain malformations, we applied targeted high-coverage sequencing (depth, ≥200×) to leukocyte-derived DNA samples from 158 persons with brain malformations, including the double-cortex syndrome (subcortical band heterotopia, 30 persons), polymicrogyria with megalencephaly (20), periventricular nodular heterotopia (61), and pachygyria (47). We validated candidate mutations with the use of Sanger sequencing and, for variants present at unequal read depths, subcloning followed by colony sequencing. RESULTS Validated, causal mutations were found in 27 persons (17%; range, 10 to 30% for each phenotype). Mutations were somatic in 8 of the 27 (30%), predominantly in persons with the double-cortex syndrome (in whom we found mutations in DCX and LIS1), persons with periventricular nodular heterotopia (FLNA), and persons with pachygyria (TUBB2B). Of the somatic mutations we detected, 5 (63%) were undetectable with the use of traditional Sanger sequencing but were validated through subcloning and subsequent sequencing of the subcloned DNA. We found potentially causal mutations in the candidate genes DYNC1H1, KIF5C, and other kinesin genes in persons with pachygyria. CONCLUSIONS Targeted sequencing was found to be useful for detecting somatic mutations in patients with brain malformations. High-coverage sequencing panels provide an important complement to whole-exome and whole-genome sequencing in the evaluation of somatic mutations in neuropsychiatric disease. (Funded by the National Institute of Neurological Disorders and Stroke and others.).
Nature | 2005
Robert Sean Hill; Christopher A. Walsh
Rapidly advancing knowledge of genome structure and sequence enables new means for the analysis of specific DNA changes associated with the differences between the human brain and that of other mammals. Recent studies implicate evolutionary changes in messenger RNA and protein expression levels, as well as DNA changes that alter amino acid sequences. We can anticipate having a systematic catalogue of DNA changes in the lineage leading to humans, but an ongoing challenge will be relating these changes to the anatomical and functional differences between our brain and that of our ancient and more recent ancestors.
Neurology | 2003
Volney L. Sheen; Meral Topçu; Samuel F. Berkovic; D. Yalnizoglu; Ilan Blatt; Adria Bodell; Robert Sean Hill; Vijay S. Ganesh; Timothy J. Cherry; Yin Yao Shugart; Christopher A. Walsh
Background: Familial periventricular heterotopia (PH) represents a disorder of neuronal migration resulting in multiple gray matter nodules along the lateral ventricular walls. Prior studies have shown that mutations in the filamin A (FLNA) gene can cause PH through an X-linked dominant inheritance pattern. Objective: To classify cortical malformation syndromes associated with PH. Methods: Analyses using microsatellite markers directed toward genomic regions of FLNA and to a highly homologous autosomal gene, FLNB, were performed on two pedigrees to evaluate for linkage with either filamin gene. Results: Two consanguineous pedigrees with PH that suggest an autosomal recessive inheritance pattern are reported. MRI of the brain revealed periventricular nodules of cerebral gray matter intensity, typical for PH. Seizures or developmental delay appeared to be a common presenting feature. Microsatellite analysis suggested no linkage to FLNA or FLNB. Conclusions: Autosomal recessive PH is another syndromic migrational disorder, distinct from X-linked dominant PH. Further classification of these different syndromes will provide an approach for genetic evaluation.
Annals of Neurology | 2013
Annapurna Poduri; Erin L. Heinzen; Vida Chitsazzadeh; Francesco M. Lasorsa; P. Christina Elhosary; Christopher M. LaCoursiere; Emilie Martin; Christopher J. Yuskaitis; Robert Sean Hill; Kutay D. Atabay; Brenda J. Barry; Jennifer N. Partlow; Fahad A. Bashiri; Radwan M. Zeidan; Salah A. Elmalik; Mohammad M. Kabiraj; Sanjeev V. Kothare; Tommy Stödberg; Amy McTague; Manju A. Kurian; Ingrid E. Scheffer; A. James Barkovich; Ferdinando Palmieri; Mustafa A. Salih; Christopher A. Walsh
To identify a genetic cause for migrating partial seizures in infancy (MPSI).
Brain & Development | 2004
Volney L. Sheen; Lina Basel-Vanagaite; Jean R. Goodman; Ingrid E. Scheffer; Adria Bodell; Vijay S. Ganesh; Robert Ravenscroft; Robert Sean Hill; Timothy J. Cherry; Yin Yao Shugart; James Barkovich; Rachel Straussberg; Christopher A. Walsh
Periventricular heterotopia (PH) represents a neuronal migration disorder that results in gray matter nodules along the lateral ventricles beneath an otherwise normal appearing cortex. While prior reports have shown that mutations in the filamin A (FLNA) gene can cause X-linked dominant PH, an increasing number of studies suggest the existence of additional PH syndromes. Further classification of these cortical malformation syndromes associated with PH allows for determination of the causal genes. Here we report three familial cases of PH with hydrocephalus. One pedigree has a known FLNA mutation with hydrocephalus occurring in the setting of valproic acid exposure. Another pedigree demonstrated possible linkage to the Xq28 locus including FLNA, although uncharacteristically a male was affected and sequencing of the FLNA gene in this individual revealed no mutation. However, in the third family with an autosomal mode of inheritance, microsatellite analysis ruled out linkage with the FLNA gene. Routine karyotyping and fluorescent in situ hybridization using BAC probes localized to FLNA also showed no evidence of genomic rearrangement. Western blot analysis of one of the affected individuals demonstrated normal expression of the FLNA protein. Lastly, sequencing of greater than 95% of the FLNA gene in an affected member failed to demonstrate a mutation. In conclusion, these findings demonstrate the etiological heterogeneity of PH with hydrocephalus. Furthermore, there likely exists an autosomal PH gene, distinct from the previously described X-linked and autosomal recessive forms. Affected individuals have severe developmental delay and may have radiographic findings of hydrocephalus.
Nature Neuroscience | 2017
Elaine T. Lim; Mohammed Uddin; Silvia De Rubeis; Yingleong Chan; Anne S Kamumbu; Xiaochang Zhang; Alissa M. D'Gama; Sonia N Kim; Robert Sean Hill; Arthur P. Goldberg; Christopher S. Poultney; Nancy J. Minshew; Itaru Kushima; Branko Aleksic; Norio Ozaki; Mara Parellada; Celso Arango; Maria Jose Penzol; Angel Carracedo; Alexander Kolevzon; Christina M. Hultman; Lauren A. Weiss; Menachem Fromer; Andreas G. Chiocchetti; Christine M. Freitag; George M. Church; Stephen W. Scherer; Joseph D. Buxbaum; Christopher A. Walsh
We systematically analyzed postzygotic mutations (PZMs) in whole-exome sequences from the largest collection of trios (5,947) with autism spectrum disorder (ASD) available, including 282 unpublished trios, and performed resequencing using multiple independent technologies. We identified 7.5% of de novo mutations as PZMs, 83.3% of which were not described in previous studies. Damaging, nonsynonymous PZMs within critical exons of prenatally expressed genes were more common in ASD probands than controls (P < 1 × 10−6), and genes carrying these PZMs were enriched for expression in the amygdala (P = 5.4 × 10−3). Two genes (KLF16 and MSANTD2) were significantly enriched for PZMs genome-wide, and other PZMs involved genes (SCN2A, HNRNPU and SMARCA4) whose mutation is known to cause ASD or other neurodevelopmental disorders. PZMs constitute a significant proportion of de novo mutations and contribute importantly to ASD risk.
Human Molecular Genetics | 2009
Fuli Yu; Alon Keinan; Hua Chen; Russell J. Ferland; Robert Sean Hill; Andre A. Mignault; Christopher A. Walsh; David Reich
Historical episodes of natural selection can skew the frequencies of genetic variants, leaving a signature that can persist for many tens or even hundreds of thousands of years. However, formal tests for selection based on allele frequency skew require strong assumptions about demographic history and mutation, which are rarely well understood. Here, we develop an empirical approach to test for signals of selection that compares patterns of genetic variation at a candidate locus with matched random regions of the genome collected in the same way. We apply this approach to four genes that have been implicated in syndromes of impaired neurological development, comparing the pattern of variation in our re-sequencing data with a large-scale, genomic data set that provides an empirical null distribution. We confirm a previously reported signal at FOXP2, and find a novel signal of selection centered at AHI1, a gene that is involved in motor and behavior abnormalities. The locus is marked by many high frequency derived alleles in non-Africans that are of low frequency in Africans, suggesting that selection at this or a closely neighboring gene occurred in the ancestral population of non-Africans. Our study also provides a prototype for how empirical scans for ancient selection can be carried out once many genomes are sequenced.
Neurology | 2009
Annapurna Poduri; Y. Wang; D. Gordon; S. Barral-Rodriguez; C. Barker-Cummings; A. Ulgen; Vida Chitsazzadeh; Robert Sean Hill; N. Risch; W. A. Hauser; T. A. Pedley; Christopher A. Walsh; Ruth Ottman
Background: Genetic epilepsy with febrile seizures plus (GEFS+) is a familial epilepsy syndrome with extremely variable expressivity. Mutations in 5 genes that raise susceptibility to GEFS+ have been discovered, but they account for only a small proportion of families. Methods: We identified a 4-generation family containing 15 affected individuals with a range of phenotypes in the GEFS+ spectrum, including febrile seizures, febrile seizures plus, epilepsy, and severe epilepsy with developmental delay. We performed a genome-wide linkage analysis using microsatellite markers and then saturated the potential linkage region identified by this screen with more markers. We evaluated the evidence for linkage using both model-based and model-free (posterior probability of linkage [PPL]) analyses. We sequenced 16 candidate genes and screened for copy number abnormalities in the minimal genetic region. Results: All 15 affected subjects and 1 obligate carrier shared a haplotype of markers at chromosome 6q16.3-22.31, an 18.1-megabase region flanked by markers D6S962 and D6S287. The maximum multipoint lod score in this region was 4.68. PPL analysis indicated an 89% probability of linkage. Sequencing of 16 candidate genes did not reveal a causative mutation. No deletions or duplications were identified. Conclusions: We report a novel susceptibility locus for genetic epilepsy with febrile seizures plus at 6q16.3-22.31, in which there are no known genes associated with ion channels or neurotransmitter receptors. The identification of the responsible gene in this region is likely to lead to the discovery of novel mechanisms of febrile seizures and epilepsy.